![](/img/cover-not-exists.png)
CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients
Alan N Gordon, Birgit C Schultes, Holly Gallion, Robert Edwards, Theresa L Whiteside, Jennifer M Cermak, Christopher F NicodemusVolume:
94
Year:
2004
Language:
english
Pages:
12
DOI:
10.1016/j.ygyno.2004.04.024
File:
PDF, 691 KB
english, 2004